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RESEARCH ARTICLE
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Abstract
Staphylococcus aureus is a human commensal that can also cause systemic infections.
This transition requires evasion of the immune response and the ability to exploit different
niches within the host. However, the disease mechanisms and the dominant immune media-
tors against infection are poorly understood. Previously it has been shown that the infecting
S. aureus population goes through a population bottleneck, from which very few bacteria
escape to establish the abscesses that are characteristic of many infections. Here we exam-
ine the host factors underlying the population bottleneck and subsequent clonal expansion
in S. aureus infection models, to identify underpinning principles of infection. The bottleneck
is a common feature between models and is independent of S. aureus strain. Interestingly,
the high doses of S. aureus required for the widely used “survival” model results in a reduced
population bottleneck, suggesting that host defences have been simply overloaded. This
brings into question the applicability of the survival model. Depletion of immune mediators
revealed key breakpoints and the dynamics of systemic infection. Loss of macrophages,
including the liver Kupffer cells, led to increased sensitivity to infection as expected but also
loss of the population bottleneck and the spread to other organs still occurred. Conversely,
neutrophil depletion led to greater susceptibility to disease but with a concomitant mainte-
nance of the bottleneck and lack of systemic spread. We also used a novel microscopy
approach to examine abscess architecture and distribution within organs. From these obser-
vations we developed a conceptual model for S. aureus disease from initial infection to
mature abscess. This work highlights the need to understand the complexities of the infec-
tious process to be able to assign functions for host and bacterial components, and why S.
aureus disease requires a seemingly high infectious dose and how interventions such as a
vaccine may be more rationally developed.
Author summary
Staphylococcus aureus is a major human pathogen that causes a wide variety of infections.
In animal infection models, high doses of S. aureus are generally required to establish infec-
tions. We have recently shown in animal models that this is due to very few bacteria within
the infecting population going on to cause disease. This population bottleneck during infec-
tion is an ideal target for treatment development. Here we have shown that this bottleneck
is common to a range of different S. aureus types and infection models. The mouse survival
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model is commonly used for testing antistaphylococcal treatments. We show that the large
infectious dose it requires diminishes the bacterial population bottleneck. This suggests the
host immune system is simply overwhelmed and brings into question the applicability of
such a model. We found that both macrophages and neutrophils are important for resis-
tance to S. aureus infection but these affect the population bottleneck differently. Macro-
phages in the liver mediate the initial population bottleneck whereas neutrophils enable the
subsequent spread of bacteria to other organs. This has allowed a model of S. aureus disease
progression to be established and our study gives insights into how novel treatments could
be established to counter it.
Introduction
Staphylococcus aureus is a leading opportunistic human pathogen renowned for its ability to
evade the immune system and cause a variety of different infections [1]. S. aureus infections
can vary from superficial skin lesions, through deep seated abscesses to life threatening sepsis
[1]. The diversity of disease modalities has made an understanding of the underlying principles
of infection challenging. S. aureus primarily occurs as a human commensal, mostly in the
nares from whence it is able to seed infection. Many S. aureus infections are iatrogenic, and
these are commonly associated with the colonisation of indwelling medical devices [2]. Typi-
cally during an infection, after invasion, an immune reaction is initiated by macrophages and
these release cytokines to summon neutrophils [3]. Fibrosis also occurs, as well as the death of
many of the invading immune cells leading to the pus filled abscesses associated with S. aureus
infections. S. aureus can also regularly escape local infection sites and disseminate further. If it
enters the bloodstream this can lead to sepsis as well as invasion of other organs whereby fur-
ther local infections can occur. Thus S. aureus infection is a highly dynamic process with
broad dissemination and repeated metastases.
Phagocytosis by professional phagocytes such as macrophages and neutrophils is the pri-
mary mode by which S. aureus is controlled by the immune system. However, S. aureus has
multiple mechanisms to subvert the immune response [4,5], including the production of a
variety of specific toxins, the ability to survive intracellularly within immune cells and the
capacity to evade capture by phagocytes. As S. aureus is effectively ubiquitous in the human
environment, our immune systems are exposed to this organism as evidenced by the signifi-
cant bloodstream titre of antibodies against a variety of S. aureus antigens [4,6–8], however
these do not necessarily afford protection against infection. It is therefore the subject of much
debate as to what are the key immune factors that control S. aureus due to the variety of possi-
ble infections as well as the many immune components involved [9,10]. This is of great transla-
tional importance as the correlates of protection against infection will determine crucial
developments such as a vaccine to prevent disease [9,10]. In order to develop the knowledge
base to underpin such an intervention it is necessary to first understand the correlates of dis-
ease, which in itself is dependent on mapping disease progression from initial infection to res-
olution in favour of the host or the pathogen.
To understand the factors that are important for disease progression it is first necessary to
determine the population, spatial and temporal dynamics of the infectious agent within the
host. This will highlight the immune breakpoints through which the pathogen must pass to
achieve a productive infection. A key way to demonstrate this has been through the creation of
multiple tagged variant strains of the pathogen of equivalent fitness and passaging them, at
specific ratios, through the relevant host model of disease [11–15]. Subsequent analysis of
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overall pathogen numbers and the ratios of the tagged strains allows determination of the
within host population dynamics. Coupling this with temporal and spatial (specific organ)
analysis provides a map of the spread and proliferation of the infectious agent, and highlights
the potential for population bottlenecks from which clonal expansion may occur. In model
animal systems this can also be combined with the manipulation of the host and/or pathogen
to determine the role of multiple factors in disease. This type of study has been very revealing
for a range of pathogens such as Streptococcus pneumoniae, Yersinia pseudotuberculosis and
Salmonella enterica [12,14,16]. We have used this approach with S. aureus to demonstrate a
population bottleneck during systemic infection in murine and zebrafish embryo models
[13,17]. An initial discovery in the zebrafish model was used to inform the design of murine
experiments. Using an intravenous administration of a mix of 3 antibiotic resistance marker
tagged S. aureus Newman HG (NewHG) clones it was found that the bacteria are initially
largely sequestered in the liver and spleen. Bacterial numbers subsequently slowly decreased in
the liver with concomitant increasing numbers in the kidneys. In the liver and spleen the initial
ratio of strains is apparent but surprisingly there is a significant alteration in strain ratio in the
kidneys consistent with individual bacteria founding the characteristic abscesses [13]. This
clonal expansion increases in all organs during infection but is most pronounced in the kid-
neys. These results show that a population bottleneck can occur in the mouse alluding to a
metastatic spread of bacteria from a primary site of infection to the kidneys. In zebrafish,
manipulation of professional phagocytes demonstrated the population bottleneck to be likely
neutrophil mediated (with the involvement of macrophages)[17,18]. Since it is mediated by
immune cells we would also define this population bottleneck as an immune bottleneck. This
provides an initial framework onto which to map within host population dynamics and the
influence of host immune defences.
The basis for key developments in our understanding of disease relies on the use of animal
models, the aim of which is to reflect facets of human disease. There are a multiplicity of S.
aureus infection models available, ranging from insects (e.g. Drosophila & Galleria), to zebra-
fish and mammals (e.g. mice and rabbits) [9,17,19,20]. Mammalian models are considered the
most apposite for S. aureus infections as they share several important characteristics with
humans, for instance body temperature, innate and adaptive immune systems and disease
pathology. However mammalian models typically require a high initial inoculum to ensure
disease initiation and many S. aureus virulence determinants are human specific [9,21]. Conse-
quently, it is difficult to equate animal model data with the human situation, particularly in the
translational context where for instance, despite promising animal model data, vaccine trials
have failed in the clinic [9,10]. Given these caveats, animal models are still important conduits
for discovery of basic disease parameters. However it is important to evaluate the relative mer-
its of the available models before relying on them to make useful conclusions.
In this study we have used 3 models of systemic disease: firstly the zebrafish model to pro-
vide initial data to inform murine studies and then the mouse sepsis and survival models (15,
18–20). The sepsis model is well established and gives a clear progression of bacterial popula-
tion dynamics [22]. The survival model has been standard for many studies and is fundamen-
tally similar to the sepsis model in that bacteria are commonly injected in to the bloodstream.
However the dose is relatively much higher to cause the subjects to succumb to infection rather
than survive and resolve as in the sepsis model [23]. The survival, or lethal challenge model,
has been in general use and is of regulatory importance [21,23,24]. Here, we have evaluated
infection dynamics in the above systemic models of infection with a suite of otherwise iso-
genic, antibiotic resistant variants of a range of S. aureus strains. This has revealed population
bottlenecks within organ pathogen spatial distribution and established the role of specific
Staphylococcus aureus infection dynamics
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immune effector cells in the dynamics of infection. This has led to the formulation of a new
conceptual model for disease progression.
Results
S. aureus population dynamics in zebrafish
To evaluate potential strain-specific and generic pathogenesis parameters the population
dynamics of a range of different S. aureus strains (Newman, NewHG, SH1000 and USA300) in
the zebrafish embryo systemic model was first determined. Three matched antibiotic resistant S.
aureus strains in the USA300 (JE2) strain background: erythromycin/lincomycin-resistant,
EryR (EPPS1); kanamycin-resistant, KanR (EPPS2); and tetracycline-resistant, TetR (EPPS3),
and the Newman strain background EryR (EPPS4), KanR (EPPS5), TetR (EPPS6) were pro-
duced by transduction of the relevant markers from the previously constructed NewHG strains
[13]. The established zebrafish embryo model of systemic disease was then used [17], whereby a
1:1:1 mixture of the variants of each strain was injected into embryos 30 hours post fertilisation
(c. 1500 CFU (colony forming units) in total), followed by monitoring of host survival. Bacteria
were harvested from embryos and their total numbers and proportions of each S. aureus strain
variant determined. Each marked variant was equally likely to predominate (group variation
was not significantly different, Bartlett’s test for equal variance USA300: p = 0.1252, Newman:
p = 0.2364), demonstrating that there were no relative fitness costs associated with the individual
antibiotic resistance markers which would undermine the analysis [11] (S1 Fig). The proportion
of the different strains was used to generate the species evenness index for the population [25],
which defines how evenly matched different populations of organisms are within an environ-
ment. A population evenness of 1 for a given population (whether it was a host or organ) means
the strain variants are evenly distributed (1:1:1 ratio) whereas 0 means the entire population
consists of one strain variant. We chose the population evenness metric as it is a commonly
accepted in ecological studies [26,27]. It is suitable as it is based on Shannon’s diversity index
which is equally sensitive to very rare and very common species in a sample. Our samples inher-
ently had these properties as the populations varied from evenly mixed to completely dominated
by 1 variant.
We found that the variants which randomly came to predominate readily occurred in both
the Newman and USA300 infected hosts, i.e. the population evenness of the injected popula-
tion started at near 1 and became 0 over the course of the experiment (Fig 1). Additionally,
there was a statistically significant correlation between time of death and decreasing popula-
tion evenness for both strain backgrounds (linear regression, USA300: P<0.0001, F = 57.39,
R2 = 0.3766, Newman: p = 0.0006, F = 13.69, R2 = 0.2504, Fig 1). The decrease in population
evenness showed that the population had an increased chance of being clonal over time. This
meant that the bacterial population in those zebrafish had passed through a likely population
bottleneck. This corresponds to the previous observation of clonality in SH1000 and NewHG
in the zebrafish model.
S. aureusmouse sepsis population dynamics
The marked strains were then used for determination of the population dynamics in the estab-
lished murine sepsis model of infection [22]. A total infectious dose of approximately 1x107
CFU was injected intravenously via the tail for each combination of marked variants in the 4
strain backgrounds (Newman, USA300, SH1000 and NewHG constructed here and previously
[13]). Mice were culled at 2, 18, 48 and 72 hours post infection. The heart, lungs, spleen, left
and right kidneys and liver were extracted from each subject, homogenised and the CFUs (col-
ony forming units) of the different marked variants determined. As for the zebrafish model
Staphylococcus aureus infection dynamics
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the species evenness index was determined. Overall the occurrence of the TetR, EryR and
KanR populations was not significantly different in the mice regardless of strain (S1 Fig, Bart-
lett’s test for equal variance, SH1000: p = 0.5598, NewHG: p = 0.8478, Newman: p = 0.9631
and USA300: p = 0.9330), demonstrating that in all strain backgrounds the antibiotic resis-
tance markers did not impart a fitness cost in the mouse model. The occurrence and distribu-
tion of S. aureus for NewHG, Newman, SH1000 and USA300 are shown in Figs 2 and S2.
Total numbers & comparative strain evenness. For all strains, there is an initial drop in
the total S. aureus CFU (2–18 hours) and then a general subsequent increase (Figs 2 and S2).
Concomitant with the rise in CFU is a progression towards predomination by particular clones
within organs suggesting a common population bottleneck during infection for all strains. Dif-
ferent organs followed specific dynamics and it has been previously shown that within 2 hours
S. aureus CFU drops below detectable limits in the blood [13].
Liver. The organ most consistently infected was the liver for all strains tested (Fig 2). 2
hours after infection every liver contained bacteria (>105 CFU). Between 2 and 18 hours there
is a drop in the CFU and after this a great variation in liver colonisation became apparent
(from clearance to 108). Over time for all strains the liver showed a significant decrease in pop-
ulation evenness, unlike the kidneys (Fig 3, linear regression, SH1000: p = 0.0076, F = 9.018,
R2 = 0.3338, NewHG: p = 0.0004, F = 18.82, R2 = 0.5254, Newman: P<0.0001, F = 73.82, R2 =
0.8040 and USA300: p = 0.0001, F = 24.47, R2 = 0.5901). The liver is the only organ that had a
consistent increase in clonality over time. Thus population dynamics in the liver begins with
the capture and subsequent clearance of the initial inoculum (which results in mixed popula-
tions occurring initially) and then proceeds to potentially be replaced by clonal expansion.
Whether clonal expansion occurs is a stochastic process likely founded from an individual bac-
terium that has escaped the initial clearance of the inoculum. We have previously determined
that individual abscesses are typically founded by low numbers of S. aureus (frequently a single
individual) [15,18].
Kidneys. It is well established that within the sepsis model kidney abscesses are a key out-
come [23]. However they are extremely variable both in terms of occurrence and CFU within
treatment groups and between strains (lower levels of kidney infection are seen in SH1000 and
Fig 1. Population evenness (PE) in zebrafish declines over time. Embryos were infected with a 1:1:1 mix of the antibiotic resistance tagged variants. The
proportions in each dead fish were analysed and the population evenness determined. (A) Population evenness over the time course of the experiment for
USA300. At each time point the following numbers of zebrafish embryos were removed due to reaching severity limits: 20hrs: 49, 28hrs:20, 44hrs:9, 52hrs:8,
68hrs:8, 76hrs:2, 90hrs:1. (B) Population evenness over the time course of the experiment for Newman. PE of 1 is a balanced mixed population whilst PE of 0
is clonal. At each time point the following numbers of zebrafish embryos were removed due to reaching severity limits: 20hrs: 49, 28hrs:6, 44hrs:15, 52hrs:6,
68hrs:9, 76hrs:3, 90hrs:4. Line: mean linear regression. Linear regression, USA300: P<0.0001, F = 57.39, R2 = 0.3766, Newman: p = 0.0006, F = 13.69, R2 =
0.2504.
https://doi.org/10.1371/journal.ppat.1007112.g001
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Fig 2. NewHG S. aureus distribution at different time points during the mouse sepsis model.Mice were infected with a 1:1:1 mixture of 3 resistance marker
tagged NewHG variants and 5 mice sacrificed at each time point. (A) The proportions of each strain at each time point in the different organs in each mouse. TetR,
EryR and KanR populations are blue, red and green respectively. The number in each pie chart represents the log amount of bacteria present (e.g. 10−6 CFU = 6).
T.O.D: Time of Death, M.N: Mouse Number. (B) The CFU load at each time point for the organs and total CFU. Organs with CFU counts below the limit of
detection (<100CFU) are represented by open circles. Error bars: mean±SD. 5 mice were sacrificed at 2hrs, 18hrs, 48hrs and 72hrs post injection of S. aureus.
https://doi.org/10.1371/journal.ppat.1007112.g002
Staphylococcus aureus infection dynamics
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Newman but greater coverage is seen in USA 300 and New HG). This indicates that the kidney
is likely a key site for abscess development but the S. aureus that initiated infection in this
organ have metastasised from (an)other infection site(s). This occurs after the immune bottle-
neck, for such variation to occur. This is further intimated to by clonality in the kidneys sam-
pled at the various time points during the experiments not fundamentally altering (unlike in
the liver). The variation in how many kidneys are infected and also how frequently one kidney
is infected but the other is not further points to the population bottleneck being elsewhere.
Over time in all strains the kidneys showed no overall significant change in clonality (linear
regression, SH1000: p = 0.5656, NewHG: p = 0.5125, Newman: p = 0.6009 and USA300:
p = 0.0587). As the organs are already consistently clonal from the earliest time points this
indicates that the bottleneck occurred previously to the infection of the kidneys. The popula-
tion bottlenecks are therefore found elsewhere.
Fig 3. Comparison of S. aureus distribution and population evenness for the different strains in the mouse sepsis model. In mice, at all time points
during infection, for all strains, the most consistently infected organ is the liver. The liver shows a statistically significant decrease in population evenness
over time after infection. The dominant strain in the liver correlates significantly with the dominant strain in the other organs and can sometimes be
found in all organs within a single mouse. Line: mean linear regression. Linear regression, SH1000: p = 0.0076, F = 9.018, R2 = 0.3338, NewHG:
p = 0.0004, F = 18.82, R2 = 0.5254, Newman: P<0.0001, F = 73.82, R2 = 0.8040 and USA300: p = 0.0001, F = 24.47, R2 = 0.5901.
https://doi.org/10.1371/journal.ppat.1007112.g003
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Spleen. With strains SH1000, New HG and USA300 bacteria were found in the spleen
sporadically throughout the course of the study. Whereas with Newman, significant, mixed
populations were found at 2 hours and 18 hours post infection (102−105). As we have previ-
ously noted [13] a proportion of the original inoculum is captured from the blood by the
spleen.
Heart & lungs. For all strains heart or lung colonisation was sporadic and CFU greater
than 103 were rare. However, if colonised these organs were likely clonal in that individual
strains predominated.
Overall within host population dynamics. The above data allows a hypothesis as to the
spatial dynamics within sepsis to be established. S. aureus loads found in organs apart from the
kidneys and liver are low and sporadic indicating that they are likely not major contributors to
the dynamics of infection. Population evenness observations in the liver and kidneys predict
that the major population bottleneck for S. aureus is potentially within the liver and other
organs become infected from there. In some mice, the most common marked variant in the
liver matched the most common variant found in other organs and on occasion the same vari-
ant or pair of variants was found in every organ within a mouse (e.g. mouse 17 in Fig 2). There
is a significant correlation between a dominant strain(s) in the liver (>50% population) and
strain(s) in other organs in the same mouse (chi-squared, NewHG: p = 0.0455, USA300:
p = 0.0039 and SH1000: p = 0.0034, Newman (insufficient data)). Conversely, this did not
occur in the correlation between the dominant strains in the kidneys and the other organs
(chi-squared, NewHG: p = 0.4450, USA300: p = 0.4028 and SH1000: p = 0.2526). Thus the
liver is the source of dissemination within the host; this phenomenon would not have been
detected by observing the kidneys alone, although this is a common practice (likely due to
abscesses being very obvious in the kidneys) [15].
The cellular basis for within host bottlenecks
As the liver is likely the source of within host dissemination, how is this mediated? Previously
we have postulated that phagocytes form the focus for the population bottleneck and it has
been demonstrated that macrophages and neutrophils are required for the control of S. aureus
infections in the mouse and zebrafish models [17,28,29]. In particular, it has been shown that
after iv injection, S. aureus is initially phagocytosed by Kupffer cells (liver macrophages) [30].
Neutrophils have also been demonstrated to act a potential “Trojan horses” carrying viable
bacteria within themselves [5].
Macrophages were depleted using clodronate vesicles [31] and, as expected, mice are conse-
quently more susceptible to S. aureus infection and so the dose was reduced to 1x105 CFU of
1:1:1 labelled NewHG. Treated mice had a significantly higher bacterial burden in the liver
compared to the control vesicle treated subjects (ANOVA, p<0.0001 Multiple comparisons
show that the clodronate treated is significantly different from the blank controls, Fig 4). An
additional replicate produced similar results (S5 Fig). Occasionally other organs, including the
kidneys, were colonised. Interestingly, population evenness was significantly increased com-
pared to the control (Kruskal-Wallis, p = 0.0002, Multiple comparisons show that the clodro-
nate treated group is significantly different from the blank controls). This increased
population evenness is due to the formation of multiple small abscesses visible on the liver
rather than a single clone emerging.
Similarly, to macrophage depletion, neutropenia (generated using anti-Ly6G antibodies)
resulted in greatly increased susceptibility to S. aureus infection with an inoculum of 5x105
CFU being used (Fig 4). Neutropenic mice demonstrated detectable bacteria almost exclusively
in the liver and in contrast to macrophage depletion these populations showed no difference
Staphylococcus aureus infection dynamics
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in population evenness compared to the control, indicating clonal expansion (Kruskal-Wallis,
p = 0.0002, Multiple comparisons show that the anti-Ly6G treated group is significantly differ-
ent from the clodronate groups but not the blank controls). The infected livers appeared pale
with no observable surface abscesses. We initially tried a lower dose of 1x105 CFU, although
there was neutrophil depletion, the resulting CFUs were no greater than the controls (again
only the livers contained S. aureus by day 3 post infection) so we increased the dose used to the
5x105 CFU results presented (additional results are shown in S5 Fig). We also depleted the
neutrophils using cyclophosphamide and an inoculum of 1x105 CFU. This again showed pale
livers, increased CFU in the livers and mostly clonal in contrast to the macrophage depletion
study (S5 Fig) and supporting our anti-Ly6G results (Liver CFU ANOVA, p<0.0001, Multiple
comparisons show that the cyclophosphamide treated group is significantly different from
both the blank controls and clodronate). However, the depletion of neutrophils was not as
complete (cyclophosphamide is generally toxic and although it depletes neutrophils in particu-
lar it also affects lymphocytes, monocytes and other fast growing cells) so the anti-Ly6G medi-
ated depletion was preferred for demonstrating the effect of neutrophils.
Whilst both macrophages and neutrophils are required for host defence compared to the
control and their loss results in greater bacterial loads (ANOVA, P<0.0001 Multiple compari-
sons show that the clodronate and anti-Ly6G treated groups are significantly different from
the blank controls) the macrophages, and not neutrophils, appear to be the basis for clonal
expansion as their depletion results in increased population evenness. Macrophage depletion
also results in greater bacterial loads than neutrophil loads when the same amount of S. aureus
is administered, further indicating that macrophages are the likely bottleneck. Conversely,
neutrophils appear to be involved in the seeding of organs from an already derived clonal pop-
ulation within the liver.
Within organ spatial population dynamics
Kidney abscesses in the sepsis model are largely clonal in that they are derived from an individ-
ual founding cell [13,18]. However, outwardly the kidneys can show a multi-lobed abscess
structure (Fig 5A). Two methods of within-organ analysis were used, both using a mixed pop-
ulation of differentially labelled bacteria to allow clonality to be determined post hoc. Firstly
mice were injected with a 1:1 ratio of 1x107 CFU NewHG GFP KanR/NewHGmCherry EryR,
and at 5 days post infection (the time by which kidney abscesses had developed), the mice
were sacrificed. Infected kidneys were serially and sequentially sectioned for CFU determina-
tion, histology and microscopy analysis of labelled bacterial populations (Fig 5B). This allowed
a reconstruction of the 3D abscess architecture. Sample organs were sectioned every 300μm
and 3x8μm sections of tissue were stained with either DAPI or Hematoxylin and Eosin (Fig 5F
and 5G). The 300μm of tissue in between these sections was homogenised and plated for CFU
determination (Fig 5D). Secondly, an optical clearing technique was employed to reveal the in
situ distribution of fluorescently labelled bacteria within the organ (Fig 5H and S1 Video).
Here lightsheet microscopy allowed a 3D rendering of the bacterial distribution to be deter-
mined [32,33].
Fig 4. Effect of neutrophil or macrophage depletion on population dynamics during infection.Mice were treated with anti-Ly6G
antibodies (neutrophil depletion) or clodronate liposomes (macrophage depletion). The bacteria were found primarily in the liver.
(A) The population evenness of the bacteria in individual livers. (B) The CFU in individual livers. Error bars: mean ± SD. (C) The
proportions of each strain in the various organs in macrophage depleted (clodronate treated) mice. (D) The proportions of each
strain in the various organs in neutrophil depleted (anti-Ly6G treated) mice. All mice were sacrificed 3 days post infection. M.N:
Mouse Number.
https://doi.org/10.1371/journal.ppat.1007112.g004
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Fig 5. The dynamics of Staphylococcus aureus abscesses within a kidney organ. (A) The left kidney after dissection and before sectioning showing the
multilobed abscesses throughout the kidney. (B) Schematic showing how a kidney was sectioned in order to determine the distribution of S. aureus
Staphylococcus aureus infection dynamics
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Overall the histological sectioning revealed that there was an uneven distribution of bacteria
within organs, with distinct foci that correlated with both CFU and visualisation of fluorescent
bacteria (Fig 5). The foci of infection consist of solid aggregates of S. aureus or scattered indi-
viduals that co-localise with areas of neutrophil infiltration (S7 Fig). Where mature abscesses
were present they almost exclusively consisted of one fluorescent variant (Fig 5C and 5D).
However, this technique resulted in the destruction of the tissue and we used new techniques
to confirm the distribution of S. aureus in the kidneys. We used lightsheet microscopy com-
bined with the optical clearing of the organs, which maintains the fluorescence of the bacteria
whilst making an abscess observable in 3D. Organ clearing and lightsheet microscopy has been
used in other systems to great effect due to preserving structures in situ and we anticipate this
technique will be of great use in S. aureus research. The lightsheet microscopy additionally
showed (beyond the details revealed by histology) that within abscesses the solid aggregates in
the kidneys were following the structure of kidney tubules in the cortex whilst the neutrophil
infiltration sites were outside the tubules (Fig 5H and S1 Video). This would not have been
demonstrated by histology alone. Based on these observations it seems likely the S. aureus is
trapped in the tubules, grows into solid aggregates and then some can subsequently escape
into the regions between the tubules where neutrophils engage the bacteria. Even in infected
organs that contain abscesses that overall are formed from more than one marked strain, there
is a clear differential distribution of clones suggesting that pervasive abscesses which have mul-
tiple foci are seeded from a single bacterium which has divided and spread to form extended
foci of infection in the surrounding tissue.
Population dynamics in the survival model
The mouse survival model has been used widely to test the efficacy of novel treatments, pro-
phylaxis and the role of bacterial and host factors in disease [21,23,34–36]. It is technically sim-
ilar to the mouse sepsis model but primarily differs in that an increased dose is given leading
to mortality as a primary output. Strains NewHG, Newman, SH1000 and USA300 were com-
pared using the survival model. For all strains a high inoculum was used (around 1x108 CFU
except USA300 which is similarly lethal at a lower dose of 3x107 CFU), made up of equal pro-
portions of the 3 antibiotic resistant marked variants in each case (Figs 6 and S3). Infection
became systemic in every subject, with bacteria across multiple organs, and typically resulted
in mouse cull within 2–3 days. Clonality (low population evenness) was much rarer at these
high doses in all organs, in all subjects, and across all 4 bacterial strains (Fig 6). It was also nota-
ble that the hearts, lungs and spleens now had high numbers of S. aureus. To determine
whether the sepsis and survival model were ends of a spectrum or independent of each other,
intermediate doses of the strains were administered to delay, and reduce, the number of sub-
jects reaching the morbidity endpoint (for all strains around 3x107 CFU except USA300 which
is similarly lethal at a lower dose of 1x107 CFU). This resulted in a lower rate of mortality (S4
Fig), with those subjects culled up to and including day 5 having more systemic infections,
whereas after this time only the liver and kidneys had bacterial loads as the infection resolves.
Lower dose survival treatments had much greater levels of clonality than the equivalent higher
dose survival treatment. Both kidneys are more frequently concurrently infected as well.
throughout the organ both through histology (Sections F and G) and CFU determination (Section D). (C) Representative image of an S. aureusmCherry
abscess. Scale bar: 100μm (D) CFU derived from homogenised sections show that the S. aureus is spatially segregated within infected organs and is unevenly
distributed. (E) Representative image of S. aureus GFP abscesses. mCherry and GFP S. aureus are very infrequently found together. Scale bar: 200μm. (F)
Fluorescent images showing the GFP tagged S. aureus in histology sections corresponding to the CFU sections. Scale bar: 3mm. (G) The corresponding H and
E stained sections showing the abscesses. Scale bar: 3mm. (H) Summary lightsheet microscopy image of a cleared kidney abscess caused by S. aureus GFP.
Scale bar: 100μm.
https://doi.org/10.1371/journal.ppat.1007112.g005
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Overall there is a significant correlation between increasing initial dose of S. aureus and the
decreasing occurrence of clonality (linear regression, p = 0.0386, F = 6.959, R2 = 0.5370, Fig 7).
There is a significant correlation between increasing clonality and increased survival by day 4
(linear regression, p=0.0049, F=18.82,R2=0.7583, Fig 7). There is also a significant correlation
between increasing initial dose of S. aureus and decreasing survival (linear regression,
p = 0.0196, F = 9.982, R2 = 0.6246). The order of increasing virulence in the survival model
was SH1000, Newman, NewHG and USA300 consistent with previous reports [37–39].
Discussion
As an opportunistic pathogen, S. aureus is able to cause a wide range of human diseases from
the superficial to potentially life threatening. There are multiple animal models of S. aureus
infection that all aim to recapitulate those events that shape the interaction between the patho-
gen and the human host. However, increasingly there is evidence that many of the virulence
determinants are human specific and thus are not relevant to the widely used animal models.
Also the route and mode of human infection is difficult to replicate in models. Murine models
of S. aureus infection are commonplace and have been one of the main tools in developing our
understanding of the disease processes. Models of sepsis (bacteraemia) are well-established
and are characterised by kidney abscesses as a primary outcome [21,23,24]. Establishment of
sepsis requires a high inoculum as is apparent in other murine models. This has been sug-
gested to be due to a bolus of bacteria being required to initiate disease [13,15]. Recently we
have shown that, in fact, there is a population bottleneck whereby likely single bacteria found
kidney abscesses [13,18]. This therefore requires an explanation as to what the series of events
that precedes abscess formation are, and the mechanism(s) involved. The individual bacteria
that found lesions occur randomly from the population in that they do not have a genetic
advantage [13,18]. Thus the initiation of abscesses is a stochastic event that is enhanced by a
Fig 6. S. aureus distribution at different time points during the mouse survival challenge model.Mice were infected with a 1:1:1 mixture of 3
resistance marker tagged NewHG variants and 5 mice sacrificed as they reached the severity limits. (A) The proportions of each strain at each time
point in the different organs in each mouse. The number in each represents the log amount of bacteria (e.g. 10−6 CFU = 6). T.O.D: Time of Death,
M.N: Mouse Number. (B) The CFU load at each time point for the organs and total CFU as well as the survival curve. On each day the following
numbers of mice were sacrificed due to reaching severity limits: Day 2:5, Day 3:12, Day 4:3. On Day 4 for the right kidney, 2 of the data points are
overlapping.
https://doi.org/10.1371/journal.ppat.1007112.g006
Fig 7. Correlation between initial inoculum, final organ clonality and survival in the mouse survival model. There is a statistically significant correlation
between increasing inocula, decreasing organ clonality and decreasing survival. (A) The correlation between starting dose and final organ clonality. (B) The
correlation between the proportion of mice that need culling by day 4 and organ clonality.
https://doi.org/10.1371/journal.ppat.1007112.g007
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large inoculum. Here we aimed to investigate within-host population dynamics and determine
the cellular basis of bottlenecks in S. aureus infection models.
The temporal and spatial dynamics of sepsis in zebrafish and murine models have been
determined using sets of marked strains in a range of backgrounds. This enabled a model for
the dynamics of infection in the mouse to be established (Fig 8). We found for all strains that
the liver was the key destination organ for the initial mixed population inoculum. Previously S.
aureus has been shown to be phagocytosed by Kupffer cells in the liver and these form a primary
immunological defence (2, 22). Subsequently expansion of individual clones occurs in the liver
or the bacterial load is cleared. Kupffer cells are effective agents for the control of S. aureus but if
this immunological bottleneck fails then bacteria are able to grow to form abscesses. Depletion
of Kupffer cells results in greatly increased host susceptibility to S. aureus infection manifested
by abscesses mostly in the livers, but also in the kidneys. Kidney abscesses develop during the
infection but these organs are not an initial colonisation site. Interestingly kidneys do not have
mixed populations that then become clonal but rather this happens at abscess initiation suggest-
ing that they are founded by single organisms or that the founders were already clonal. Given
the complex population dynamics in the liver we suggest that it is the transfer of S. aureus from
the liver that gives rise to kidney colonisation. But how therefore do the bacteria traffic between
organs? A clue to this comes from the generation of neutropenia within the mouse. Interestingly
loss of neutrophils results in no loss of clonality within the liver. Thus the neutrophils are not
the primary bottleneck within the liver. However, subsequent abscess formation was abrogated
within the kidneys. The importance of neutrophils for dissemination correlates with other
research that shows that S. aureus can live intracellularly within phagosomes and be transported
by them in the blood, forming a mobile reservoir to infect other organs [5,40,41]. Also, treat-
ment with antibiotics that do not penetrate the neutrophil phagosome do not prevent internal
dissemination of S. aureus [30,42]. However, conventionally neutrophils that mature and enter
infected tissue do not re-enter the blood stream [28,43]. The most parsimonious explanation is
that neutrophils that are already circulating in the blood (whose population greatly increases in
response to infection) take up S. aureus that escape into the blood stream from the lesions in the
liver. This could be due to abscesses/microlesions shedding S. aureus into the blood stream, as is
known to occur in clinical infections [44].
Kidney CFU alone is used as a readout in many studies of S. aureus disease, for which one
might express caution as if bacteria have passed through the liver bottleneck then they can
clonally expand and so the subtleties of S aureus infection prior to this point will be lost. Liver
CFU provides a useful adjunct to kidney numbers. It might seem surprising that a kidney with
many apparent surface abscesses could in fact be seeded by an individual founder. It is also
important to note that it is unlikely that apparently clonal organs are founded by multiple bac-
teria of the same type as left and right kidneys are often clonal but with different clones. In
order to determine how a single organism could establish a disseminated abscess throughout a
kidney we began to map the 3D architecture of the abscess. We developed two methods to
address this conundrum. Serial organ sectioning revealed foci of infection with the characteris-
tic abscess structure of infiltration of phagocytes but these extended throughout the kidney
forming a seemingly linked series of lesions. Organ clearing is a new approach to study infect-
ing organisms within host tissue and here it revealed a pervasive spread of S. aureus as solid
aggregates within cortex tubules and as diffuse groupings with infiltration of phagocytes out-
side these tubules [33,45].
The scheme presented in Fig 8 suggests the presence of two immunological bottlenecks
within the murine sepsis model. Firstly, at the level of Kupffer cells in the liver and then at the
neutrophils when disseminating from the liver. Zebrafish embryos do not have Kupffer cells at
the time of infection. In the zebrafish the population bottleneck occurs in the phagocytes but is
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mainly believed to be due to the neutrophils[18]. Our mouse models therefore apparently
diverge from the zebrafish model on the relative importance of the two major classes of profes-
sional phagocytes. This study provides data that phagocytes present a key breakpoint during
infection in that these cells are absolutely required for host resistance but also permit prolifera-
tion as “Trojan Horses” as has been previously proposed [40]. The question arises however as
to whether this hypothesis translates into a human infection both in terms of the immune sys-
tem and the occurrence of population bottlenecks. The murine sepsis model shares several
characteristics that are known to occur within human infections such as how S. aureus can dis-
seminate in the blood stream to different organs from an initial infection site and the forma-
tion of localised abscesses in separate organs.
It is known that professional phagocytes are key to controlling S. aureus infections but that
S. aureus can also hide intracellularly [5,28]. What we have found correlates with human infec-
tions. In our model both neutrophils and macrophages are important for controlling S. aureus
infection and the same is true in humans as shown by various genetic disorders in these can
result in increased S. aureus infections [46]. This is however more commonly associated with
Fig 8. A model of the internal transmission of S. aureus.With a high inoculum the host is rapidly overwhelmed by a systemic infection. With a moderate inoculum a
more dynamic infection occurs. Injected S. aureus travels through the vasculature. Bacteria are then phagocytosed by the Kupffer cells (liver macrophages), with resulting
containment and killing. However a few S. aureus survive and are able to form viable extracellular microlesions. Local neutrophils are recruited to aid in their control. As
the abscess develops some S. aureus can likely escape into the blood. S. aureus can then seed the kidneys that can then go on to form large clonal abscesses. If both
macrophages and neutrophils are unsuccessful in clearing the infection in the liver then clonal abscesses can also form there.
https://doi.org/10.1371/journal.ppat.1007112.g008
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neutrophil disorders (which may reflect how macrophages are generally less dispensable as
they are required for tissue development and homeostasis).
One particular point is that our model shows that the liver is the site of the primary bottle-
neck. Generally, in humans, the liver is not a site particularly associated with S. aureus infec-
tion (compared to soft tissue infections or deep infections such as osteomyelitis) so it would
seem unlikely it would have the same role in humans. However, patients with chronic granulo-
matous disease (lacking the respiratory burst part of phagocytosis) have a particularly high risk
of staphylococcal liver abscesses [46,47]. This implies that in normal people S. aureus can be
cleared from the liver as a normal process, which would be by the action of Kupffer cells, the
resident professional phagocytes. Our results suggest that the killing activity of macrophages
on S. aureus should be worthy of further study but also the ability of neutrophils to transfer S.
aureus between organs should also be of great interest as has been shown by other methods
[5,30].
Genome studies have shown that there are repeated genetic population bottlenecks and that
these occur both during transmission and the shift from colonisation to disease [48–50]. In
human infections, population bottlenecks would be interacting with the inherent variation of
the naturally colonising S. aureus population as infections tend to be derived from the previous
resident S. aureus [48]. The existence of stochastic niches and resource limitation (here access
to host nutrients) according to ecological studies are intrinsically supposed to maintain
increased population diversity particularly if they are better at competing for different
resources [51]. Population bottlenecks, as the host is infected, would form stochastic niches
and the exact site would exert different selection pressures. They could therefore work to
maintain population diversity and increased strain divergence as the population bottleneck
would randomly exclude different subpopulations upon each infection. This may be reflected
in the diversity of virulence factors that different strains of S. aureus possess and the mainte-
nance of different clones of S. aureus [52]. Population bottlenecks would also favour variants
that are better at getting through it rather than selecting for mutants fitter after subsequent
diversification. This concurs with the diversity seen in Young during colonisation and the
more limited subsequent diversification [48].
A population bottleneck results in a notable distribution of the observable population.
There are members of the administered dose that pass through and come to dominate the pop-
ulation and then there are those that are excluded, which ultimately means there tends to be
two groups of data: mixed populations that have not yet passed through the bottleneck and
populations that have become, or are rapidly becoming, clonal (as one strain is expanding rela-
tive to the others). This can be seen in our data as organs with a mixed population with all 3
strains present and organs with clonal populations. It is reasonable to make assessments based
on the proportion of a population that was mixed or clonal as we have done but it would be
much harder to assess if one population was becoming clonal more quickly than another (e.g.
if one strain or another was better at expanding out of the macrophage bottleneck).
Population bottlenecks during infection represent key breakpoints for interventions.
Despite apparent success in animal models, vaccine development for S. aureus has not trans-
lated into successful human trials [10,53]. Active vaccination is by its nature prophylaxis and
thus the target should be to prevent the ability of S. aureus to pass through bottlenecks and
proliferate. The knowledge that intracellular organisms form this nexus within phagocytes
provides a key parameter from which to design future vaccine formulations. Recent evidence
highlighting the targeting of intraphagocytic S. aureus supports such an approach [42]. This is
consistent with what has been found previously, in that S. aureus can survive within neutro-
phils; and treating mice with antibiotics that do not affect intracellular S. aureus does not pre-
vent dissemination [5,30].
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Our work, as well as highlighting the cellular locations of immunological bottlenecks also
sheds light on the role of the infectious dose on the outcome of infection and the population
dynamics therein. The survival challenge model is a standard in the field and has been used in
many studies [21,24]. Measuring population dynamics within this model showed a clear dimi-
nution of population bottlenecks correlating with an increased infectious dose leading to host
morbidity. High infectious doses result in systemic infections across all major organs. The rele-
vance of this model is therefore bought into question as clearly those immunological processes
that control the dynamics of infection have been overwhelmed. This observation is therefore
of great importance for the design of intervention studies where one is modelling human
infection and not uncontrolled bacteraemia. Using lower doses is more realistic as well as
allowing population bottlenecks to occur as infectious doses of S. aureus are likely to be inher-
ently lower in humans compared to our mouse models. In Grice et al punch biopsies were
used which gave total bacterial numbers of at least 106 CFU/cm2[54]. In a study of vascular
catheters, a range of bacteria were found with numbers up to 107 CFU [55]. In a given infec-
tion it is likely that only a fraction of these would be able to disseminate from the skin or
implant. This is reflected in bacteraemia where the count is typically<10 CFU per ml [56].
The number of bacteria that can transfer to infect organs is much less than>5 x 107 CFU per
ml murine blood if 108 CFU is injected (assuming 1.5 ml of blood per 25g mouse).
The threat of antimicrobial resistance to human healthcare is real and increasing. Disease is
a complex and dynamic interplay between host and a population of infectious agent. Here we
have highlighted key parameters of how S. aureus disease progresses and provide a framework
for determination of efficacy of new interventions.
Materials & methods
Ethics statement
Animal work (both mice and zebrafish) was carried out according to guidelines and legislation
set out in the UK Animals (Scientific Procedures) Act 1986, under Project Licenses PPL 40/
3699 and PPL 40/3574. Ethical approval was granted by the University of Sheffield Local Ethi-
cal Review Panel.
Bacterial strains and growth conditions
Staphylococcus aureus strains (S1 Table) were grown using brain heart infusion (BHI) liquid or
solid medium (Oxoid) at 37˚C, supplemented with the following antibiotics where appropri-
ate: kanamycin 50 μg/ml, tetracycline 5 μg/ml or erythromycin 5 μg/ml plus lincomycin 25 μg/
ml (Sigma-Aldrich).
Construction of antibiotic resistant strains
S. aureus TetR, EryR and KanR strains used included those constructed previously [13]. The
resistance markers were transferred into further strain backgrounds using ϕ11 transduction
[57]. ϕ11 variants of suicide vector pMUTIN4 were used to integrate various antibiotic resis-
tance cassettes downstream of the lysA gene in S. aureus in the original strains [13]. The geno-
mic region surrounding lysA is conserved in the Newman and USA300 genomes.
Construction of fluorescent strains
The suicide vector pKASBAR (and pKASBARkan) was used to integrate constitutive GFP and
mCherry fluorescence markers with promoter Pma1M from the E. faecalis pmv158GFP and
pmv158mCherry plasmids into the S. aureus lipase gene in RN4220 [58,59]. The fluorescent
Staphylococcus aureus infection dynamics
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007112 June 14, 2018 18 / 27
markers were then transferred into SH1000, Newman, NewHG and USA300 by ϕ11 transduc-
tion. This resulted in strains which were GFP KanR or mCherry TetR.
Construction of fluorescent strains–GFP strains
A fragment of c.1200 bp containing the GFP encoding gene and its promoter sequence was
amplified by PCR from pMV158GFP plasmid using the following primers:
EP01 cctttttttgccccgggatcCTATTTGTATAGTTCATCCATGC
EP02 ctatgaccatgattacgaattcAGCTTGATTTGATAGCATAATTTTG
The PCR fragment was cloned into pKASBARkan by Gibson assembly, with the plasmid cut
by EcoRI and BamHI [58].The resulting plasmid pKASBARGFPkan was introduced into E. coli
NEB5-alpha by electroporation with selection for ampicillin resistance. The correct plasmid was
confirmed by sequencing and used to transform S. aureus competent cells RN4220 containing a
helper plasmid pCL112ï19 and then selected for with Kanamycin[60]. The marker was then
transferred into the NewHG strain (and other backgrounds) by ϕ11 transduction.
Construction of fluorescent strains–mCherry strains
A fragment of c.1200 bp containing the mCherry encoding gene and its promoter sequence
was amplified by PCR from pMV158mCherry plasmid using the following primers:
PTS01 cctttttttgccccggGAGCTCGGTACCCAGCTT
PTS02 ctatgaccatgattacgTTAATGATGATGATGATGATGAGATCTTTTATATAATTC
The PCR fragment was cloned into pKASBAR by Gibson assembly with the plasmid cut by
EcoRI and BamHI[58]. The resulting plasmid pKASBARmCherry was introduced into E. coli
NEB5-alpha by electroporation with selection for ampicillin resistance. The correct plasmid was
confirmed by sequencing and used to transform S. aureus competent cells RN4220 containing a
helper plasmid pCL112ï19 and then selected for with tetracycline [60]. The marker was then
transferred into NewHG (and other backgrounds) by ϕ11 transduction. The generated strains
however showed only weak tetracycline resistance and were therefore supplemented by EryR
from SJF3673 strain collection (lysA::ery lysA+) by ϕ11 transduction. Transductants with supple-
mented EryR were verified by PCR.
Zebrafish maintenance and microinjection
London wild-type (LWT) zebrafish embryos (bred in the MRC CDBG aquarium facilities at
the University of Sheffield; see Ethics Statement) were used for all experiments and were incu-
bated in E3 medium at 28.3˚C according to standard protocols [61]. Anaesthetized embryos at
30 hours post fertilization were embedded in 3% w/v methylcellulose and injected individually
using microcapillary pipettes filled with bacterial suspension of known concentration into the
blood circulation, as previously described [17]. Following infection, embryos were kept indi-
vidually in 100 μl E3 medium, and observed frequently up to 90 hours post infection; dead
embryos removed and CFU from these embryos recorded at each time point.
Intravenous mouse injections
6–7 week old Female BALB/c mice were purchased from Envigo (formerly Harlan (UK)) and
maintained at the University of Sheffield using standard husbandry procedures. The mice
were acclimatised for 1 week. The mice were then inoculated in the tail vein with 100 μl of S.
aureus suspension in endotoxin-free PBS (Sigma) diluted from frozen stocks. Viable bacteria
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in the inoculum were plated on TSB (plus appropriate antibiotics) after serial decimal dilution
to confirm the accuracy of the bacterial dose. Mice were monitored and sacrificed at various
time-points according to experimental design.
Mouse sepsis model design
All mice were injected with 1x107 CFU S. aureus consisting of a 1:1:1 ratio of KanR, EryR &
TetR variants of the different strains (SH1000, Newman, NewHG, USA300). 5 mice were sacri-
ficed at the following time points post infection: 2hrs, 18hrs, 48hrs, 72hrs (end of procedure)
Mouse survival challenge model design
The mice were injected with the following doses of S. aureus to reflect different levels of chal-
lenge that result in both low and high levels of mice that reach the severity limits. The higher
dose set: SH1000: 1x108 CFU, NewHG: 1x108 CFU, Newman: 9x107 CFU, USA300: 3x107
CFU The lower dose set: SH1000: 3x107 CFU, NewHG: 3x107 CFU, Newman: 3x107 CFU,
USA300: 1x107 CFU.
Immune modulation–Macrophage depletion
Macrophages were depleted using clodronate liposomes following previously published proto-
cols (NvR, http://www.clodronateliposomes.org/)[30,31]. The mice were injected iv with 1ml
of liposomes per 100g on day 1. The mice were then injected with 1x105 CFU S. aureus on day
2. Mice were sacrificed on day 5 (3 days post infection). Blank liposomes were used as a con-
trol. Macrophage depletion was confirmed in pilot studies using histology sections of the liver
stained with F4/80 from Serotec AbD Serotec MCA497, followed by an anti-rat red fluoro-
phore. The results confirming macrophage depletion are shown in S6 Fig.
Immune modulation–Neutrophil depletion
Neutrophils were depleted using anti-Ly6G mouse antibodies following previously published
protocols [62]. For antibody based neutrophil depletion Invivo anti-Ly6G mouse antibody
(1A8, BioXcell) was used [62]. The mice were injected with 1.5mg/mouse (200ul per mouse)
on day 1 with the mice being injected with S. aureus on day 2. Mice were sacrificed on day 5 (3
days post infection).
For cyclophosphamide depletion mice were injected intraperitoneally with 150mg/kg cyclo-
phosphamide monohydrate (Sigma, also known as Cyclophosphamide & Cytoxan) on day 1
and 100mg/kg cyclophosphamide intraperitoneally on day 4. The mice were injected with
20mg/ml cyclophosphamide reconstituted in etox free water. The mice were then injected
with S. aureus on day 5. Mice were sacrificed on day 8 (3 days post infection).
Neutrophil depletion was confirmed using flow cytometry. 100μl of blood was collected via
tail bleeding at the same time as S. aureus was injected and 100μl was collected at the end of
the experiment via terminal anaesthesia and heart puncture. These blood samples were each
mixed with 20μl of Heparin. The blood samples were stained with APC Rat Anti-Mouse Ly6G
antibody (BD biosciences, cat. No: 560599) according to the BD bioscience protocol for
Immunofluorescent Staining of Mouse and Rat Leukocytes and Fixation with fixation buffer
(cat. No: 554655). (http://www.bdbiosciences.com/eu/resources/s/mouseratleukocytes). The
samples were then processed using the BD LSRII flow cytometer. The results confirming neu-
trophil depletion are shown in S6 Fig.
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Determination of in vivo bacterial load
In order to recover bacteria from host tissues, whole zebrafish embryos or mouse organs were
individually homogenized in a suitable volume of PBS using the PreCellys 24-Dual (Peqlab)
[13]. Homogenates were serially diluted in PBS and plated on TSB (S. aureus) or TSB supple-
mented with appropriate antibiotics (tetracycline, erythromycin or kanamycin) to determine
bacterial numbers. The limit of detection was defined as<100 CFU as defined previously and
these results were treated as 0 CFU [13].
Tissue sectioning and visualisation of fluorescent strains
Mice were injected with a 1:1 ratio of 1x107 CFU NewHG GFP KanR/NewHGmCherry EryR,
and at 5 days post infection the mice were sacrificed, organs with notable abscesses were sec-
tioned and histology performed. The selected organs were sectioned evenly throughout. Every
300μm, 3 sections (8μm each) of tissue were stained with either DAPI, Hematoxylin and
Eosin, or Gram stain. The 300μm sections in between were homogenised separately and plated
out for bacterial enumeration as described above. DAPI stained tissue sections were analysed
using a Nikon Dual Cam fluorescent microscope whilst the Hematoxylin and Eosin or Gram
stained slides were analysed using an Aperio digital microscope slide scanner. Other organs
were optically cleared using the ScaleS protocol and were visualised using a Zeiss Z1 lightsheet
microscope [33].
Statistical analysis
Survival experiments were evaluated using the Kaplan-Meier method. Comparisons between
curves were performed using the log rank test. For comparisons between CFU groups, a two-
tailed, unpaired ANOVA was used. For comparisons of strain ratios where 3 strains were
tested (e.g. TetR, EryR and KanR), species evenness was calculated per sample (Species even-
ness is Shannon’s diversity index H divided by the natural logarithm of species richness ln(S))
and then compared using a (non-parametric) Kruskal-Wallis test. Bartlett’s test for equal vari-
ance was used to test if the mixed strains were equally fit (population spread should be equal).
For comparing correlations linear regression was used and the mean was presented on corre-
sponding graphs. All statistical analysis was performed using Prism version 6.0 (GraphPad)
and statistical significance was assumed at p<0.05. Error bars indicate mean ±One Standard
Deviation.
Supporting information
S1 Fig. Numbers of each strain in the zebrafish and mouse sepsis model for demonstration
of equal fitness. The combined CFU from each strain for each individual zebrafish in the zeb-
rafish studies (A) and for all organs for each individual mouse is presented for the mouse sepsis
studies (B). This demonstrates that in both models that none of the marked strains has a sur-
vival advantage over the other marked strains.
(TIF)
S2 Fig. S. aureus distribution at different time points during the mouse sepsis model for
SH1000 (A), Newman (B) and USA300 (C).Mice were infected with a 1:1:1 mixture of 3
resistance marker tagged variants for each strain. For each panel, above shows the proportions
of each strain at each time point in the different organs in each mouse. The number in each
represents the log amount of bacteria (e.g. 10−6 CFU = 6). Below shows the CFU load at each
time point for the organs and total CFU. Organs with CFU counts below the limit of detection
(<100CFU) are represented by open circles. Error bars: mean ± SD. 5 mice were sacrificed in
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each study at 2hrs, 18hrs, 48hrs and 72hrs post injection of S. aureus.
(PDF)
S3 Fig. S. aureus distribution at different time points during the mouse survival model for
USA300 (A), Newman (B) and SH1000 (C).Mice were infected with a 1:1:1 mixture of 3
resistance marker tagged variants and 5 mice sacrificed as they reached the severity limits. For
each panel, above is shown the proportions of each strain at each time point in the different
organs in each mouse. The number in each represents the log amount of bacteria (e.g. 10−6
CFU = 6). Below is shown the CFU load at each time point for the organs and total CFU as
well as the survival curve. The population evenness of the liver and all the individual organs is
also shown. For the USA300 study, on each day the following numbers of mice were sacrificed
due to reaching severity limits: Day 2:4, Day 3:4, Day 4:3, Day 5:2, Day 6:2, Day 11: 5 (end of
procedure). For the Newman study, on each day the following numbers of mice were sacrificed
due to reaching severity limits: Day 2:1, Day 3:8, Day 4:8, Day 5:3. For the SH1000 study, on
each day the following numbers of mice were sacrificed due to reaching severity limits: Day
1:1, Day 2:4, Day 3:3, Day 4:4, Day 5:2, Day 6: 2, Day 11: 4 (end of procedure).
(PDF)
S4 Fig. S. aureus distribution at different time points during the mouse survival model
(lower dose) for NewHG (A), SH1000 (B), USA300 (C) and Newman (D).Mice were
infected with a 1:1:1 mixture of 3 resistance marker tagged variants and 5 mice sacrificed as
they reached the severity limits. Here the mice were given a substantially lower dose than in
the other survival studies. For each panel, above is shown the proportions of each strain at
each time point in the different organs in each mouse. The number in each represents the log
amount of bacteria (e.g. 10−6 CFU = 6). Below is shown the CFU load at each time point for
the organs and total CFU as well as the survival curve. The population evenness of the liver
and all the individual organs is also shown. For the NewHG study, the following numbers of
mice were sacrificed due to reaching severity limits: Day 2:4, Day 3:3, Day 4:2, Day 5:3, Day
8:1, Day 9:1, Day 10:1, Day 11:5 (end of procedure). For the Newman study, the following
numbers of mice were sacrificed due to reaching severity limits: Day 3:3, Day 4:2, Day 5:5, Day
6:2, Day 7:1, Day 8:3, Day 10:1, Day 11: 3 (end of procedure). For the USA300 study, on each
day the following numbers of mice were sacrificed due to reaching severity limits: Day 2:2,
Day 4:2, Day 11: 16 (end of procedure). For the SH1000 study, on each day the following num-
bers of mice were sacrificed due to reaching severity limits: Day 4:1, Day 6:1, Day 8:1, Day 11:
17 (end of procedure).
(PDF)
S5 Fig. Macrophage and neutrophil depletion studies. (A) The proportions of each strain in
the various organs in control mice (blank liposomes) injected with 1x105 CFU (counts and
diversity shown in Fig 4A and 4B). (B) The proportions of each strain in the various organs in
mice injected with 1x105 CFU and clodronate. In a repeat of the previous study shown in Fig
4, mixed populations occur in the liver and spread to other organs occurs. (C) The proportions
of each strain in the various organs in mice injected with 1x105 CFU and anti Ly-6G. Again
the liver populations are largely clonal and there is no spread to other organs. However the
numbers were equivalent to the blank controls so consequently the dose was increased the
dose for the depletion study (Fig 4). (D) The proportions of each strain in the various organs
in mice injected with 1x105 CFU and cyclophosphamide. There are higher loads in the livers
and clonality occurs. All mice were sacrificed 3 days post infection apart from the cyclophos-
phamide study where the mice were sacrificed due to hitting severity limits as follows: Day 1:2,
Day 2:5, Day 3: 3 (end of procedure). (E) The CFU in individual livers. (F) The population
Staphylococcus aureus infection dynamics
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007112 June 14, 2018 22 / 27
evenness of the bacteria in individual livers. Error bars: mean ± SD.
(PDF)
S6 Fig. Macrophage and neutrophil depletion controls. (A) Representative liver sections
from a control mouse, (B) Representative liver sections from a mouse treated with clodronate.
Both sections were stained with antibody against the macrophage marker F4/80 (Biorad,
MCA497) then stained with an anti-rat red fluorescent antibody. Few if any macrophages are
visible in the clodronate treated mice. Scale bars: 50μm. (C) Representative flow cytometry
from a non-treated control mouse. (D) Representative flow cytometry from a mouse treated
with anti-Ly6G antibody. (E) Proportional neutrophil counts in Neutrophil depleted mice
against a control group of non-treated mice (n- = 3). Very few neutrophils are detectable in
treated groups compared to the infected controls, although some are present in the cyclophos-
phamide treated group.
(PDF)
S7 Fig. Neutrophils are present in abscesses in kidneys.Neutrophils are found surrounding
S. aureus aggregates in abscesses as shown in serial sections. (A) One section showing a S.
aureus GFP aggregate. (B) The serial section below stained with Haematoxylin and Eosin
showing the neutrophils surrounding it. (C) Another section showing a mix of aggregates and
diffuse groupings of S. aureus GFP. (D) The serial section below stained with Haematoxylin
and Eosin showing the neutrophils surrounding these bacteria as well as fibrosis around the
abscess.
(PDF)
S1 Video. S. aureus distribution within an abscess. A lightsheet microscope was used to visu-
alise a kidney abscess caused by S. aureus GFP that had been cleared with the scale S technique.
The video rotates around a mature kidney abscess starting outside the kidney, the S. aureus
GFP (green) is readily visible whilst the background fluorescence of the tissue has been used to
render the kidney tubules observable. Within the abscess the S. aureus GFP is found both as
solid aggregates within the microtubules and diffuse groupings outside the microtubules (it is
likely they have been phagocytosed by neutrophils here), indicating heterogeneous behaviour
of the S. aureus. This would not have been directly observable without this technique.
(MP4)
S1 Table. Bacterial strains and plasmids used in this study.
(PDF)
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